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Association of the ribosome-inactivating proteins (RIPS): pokeweed antiviral protein (PAP), gelonin, 
Momordica charantia inhibitor (MCI), with reconstituted Sendai virus envelopes (RSVE) was obtained 
without detectable loss of activities either of RIPS or of viral envelope glycoproteins. RIPS are inactive 
towards intact cells, but, once encapsulated in RSVE, they become cytotoxic. The concentration of RSVE- 
associated PAP, which causes 50% inhibition of protein synthesis by Friend erythroleukemic ells, is 
0.5 ng/ml. Substances capable to inhibit the viral activities block the acquired cytotoxicity of RIPS 
associated to RSVE. 
Ribosome inactivating protein Sendai virus 
1. INTRODUCTION 
Intensive efforts, in many laboratories, are 
devoted to develop biological tools capable of 
eliminating selected populations of cells. Specific 
cytotoxic agents have been prepared by con- 
jugating toxins (diphtheria toxin, ricin or abrin) to 
suitable carriers, such as antibodies (for review see 
[l]). To overcome the disadvantages of’ using 
whole toxins (mainly connected with lack of 
specificity), their active fragments (A-chains) have 
been used to construct conjugates [l]. The A- 
chains, when separated from the cell-binding B- 
chains, are non-toxic to intact cells, and still retain 
their capability of inactivating enzymically the 
elongation factor 2 (diphtheria toxin A-chain), or 
Abbreviations: CHO, Chinese hamster ovary; DTA, 
diphtheria toxin A-chain; DTT, dithiothreitol; IDso, 
concentration causing 50% inhibition; MCI, Momor- 
dica charantia inhibitor; PAP, pokeweed antiviral pro- 
tein (prepared from seeds, PAP-S [15]); PMSF, p- 
methylsulphonylfluoride; RIP, ribosome-inactivating 
protein; RSVE, reconstituted Sendai virus envelope 
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eukaryotic ribosomes (ricin and abrin A-chains). 
However, the isolated A-chains have several 
drawbacks, such as instability or contamination by 
whole toxin; moreover, antibodies are often less 
efficient than B-chains in mediating the entry of A- 
chains into cells [2]. 
Aim of-the present experiments was to produce 
a cytotoxic agent wherein the active moiety retain- 
ed full activity, and as much as possible of it could 
be delivered into cells. As active moieties we used 
some ribosome-inactivating proteins (Momordica 
charantia inhibitor, gelonin and pokeweed an- 
tiviral protein) which are easily purified from 
seeds, and act as the A-chains of ricin and abrin 
(for review see [3]). Like the A-chains, RIPS do not 
bind to cells, have a low intrinsic toxicity, and can 
acquire toxicity upon conjugation to con A [3], to 
monoclonal anti-Thy 1.1 antibody [5], and to the 
Fab’ fragment of IgG [a], or by inclusion into 
liposomes [7]. Liposomes have the great advantage 
of carrying a larger amount of unmodified protein; 
however, they are internalized into cells by en- 
docytotic processes, and consequently most of the 
macromolecules they deliver are degradated [8]. 
150 
Published by Elsevier Science Publishers B. V. 
00145793/83/$3.00  1983 Federation of European Biochemical Societies 
Volume 157, number 1 FEBS LETTERS June 1983 
To overcome this difficulty, we used reconstituted 
envelopes of Sendai virus, which had been 
employed successfully to transfer into cell-active 
macromolecules (for review see [9]), among which 
the A-chain of diphtheria toxin [lo]. 
RSVEs, like Sendai virions, bind to cell plasma 
membranes containing sialic acid through the viral 
haemagglutinating-neuraminidase glycoprotein 
HN. Subsequently the viral glycoprotein F 
mediates the fusion between viral envelope and 
recipient cell plasma membrane, and thus the viral 
content is transferred to the host cells [ll]. 
The association of RIPS with RSVEs was quan- 
titatively considerable and at least comparable to 
that of DTA. RSVE-mediated entry of RIPS into 
cells was higher, by some 3 orders of magnitude, as 
compared with the liposomal system [7]. As a 
result, RSVE-associated RIPS were highly toxic to 
CHO, and even more to Friend’s erythroleukemic 
cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Sendai viruses were prepared, and their activity 
determined as reported in [12]. Diphtheria toxin A- 
chain, prepared from nicked purified toxin [13], 
was a generous gift of L. Montanaro (Istituto di 
Patologia Generale, Bologna). Gelonin [4], MCI 
[14] and PAP [15] were purified from the seeds of 
Gelonium multijTorum, Momordica charantia and 
Phytolacca americana, respectively. RIPS were 
freeze-dried and stored at - 25°C. RIPS and DTA 
were radiolabelled by the iodogen procedure [la] 
using 18.5 MB9 of carrier-free [‘251]iodide (Amers- 
ham International). 
2.2. Preparation of reconstituted viral envelopes 
Association of RIPS or DTA with RSVE was ob- 
tained by following the procedures in [ 171. Briefly, 
10 mg of viral protein was dissolved in 0.4 ml of 
150 mM NaCl, 20 mM Tris-HCl, pH 7.4 (TBS), 
containing 2% Triton X-100. After 1 h at room 
temperature, the insoluble material was removed 
by centrifugation (100000 x g, 1 h, 4°C) and 
2.5 mg of RIP or DTA in 0.4 ml TBS were mixed 
with the solubilised viral envelopes. Triton X-100 
was removed by dialysis for 72 h in Spectrapor 2 
(Spectrum Medical Industries) against 1 g of Bio 
Bead SM2 (Bio-Rad Laboratories) in TBS. The 
formed vesicles were isolated by centrifugation 
(100000 x g, 1 h, 4°C). 
2.3. Protein synthesis 
2.3.1. Cell-free system 
Cell-free protein synthesis was measured as in 
[14] with a rabbit reticulocyte lysate [18]; for 
details see table 1. 
2.3.2. Cells 
Chinese hamster ovary (CHO) cells and mouse 
Friend’s 745 erythroblastoid cell lines were 
cultured at 37°C as monolayers, and suspensions 
in Falcon Tissue-culture ware in Eagle’s medium 
supplemented with 10% (v/v) foetal calf serum. 
The effect on cellular protein synthesis was 
measured after addition of RSVE containing RIPS 
or DTA both in monolayer cultures in Limbro 
24-well tissue-culture plates (CHO cells), and in 
suspension cultures in 12 x 75 mm Falcon tubes 
(Friend’s cells). Confluent cultures (CHO cells) or 
2 x lo6 cells/ml (Friend’s cells) were rinsed with 
Hank’s solution and were incubated at 37°C for 
30 rnin with various concentrations of 
RSVE-RIPS or RSVE-DTA, and then were rinsed 
twice with Hank’s solution. Cells were incubated 
in Eagle’s medium containing 5% heat-inactivated 
foetal calf serum, which after 6 h (CHO cells) or 
21 h (Friend’s cells) was substituted by fresh 
medium without serum and containing 
l-2 &i/ml of L-4,5-[3H]leucine (spec.act. 
55 Ci/mmol, Arnersham International). After 1 h 
at 37°C the radioactivity incorporated was 
measured as in [ 191. 
3. RESULTS 
RIPS were associated to RSVE with different 
yields (table 1). Association of inhibitory proteins 
with RSVE was estimated from the recovery of 
‘251-labelled proteins, and from the inhibitory ac- 
tivity on cell-free protein synthesis. Both methods 
may be inaccurate, the first one owing to low 
counts, and the second owing to possible inactiva- 
tion of the protein during the entrapping pro- 
cedure. When RIPS were released from RSVE by 
treatment with 1% (v/v) Triton X-100, a 2-3-fold 
increase of their activity was observed in all cases 
(table 1). Attempts to separate previously 
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Table 1 
Association of inhibitory proteins with reconstituted Sendai virus envelopes and their effect on protein synthesis 
ZDso/mg of RSVE protein Protein recovered 
+g/mg RSVE) 
RIP ZZho/rng 
of native 
RIP + Triton X-100 From activity From 12’1 
PAP 900900a 
MCI 606300a 
Gelonin 80000’ 
DTA 3600b 
a From [3] 
b Determined in the present work 
10500 23 500 26.0 40-60 
375 1000 1.6 Cl0 
1400 3400 42.5 18 
22 30 8.2 < 10 
Protein synthesis was evaluated in the lysate system as described in the text. Reaction mixtures (62.5 ~1) contained: 
10 mM Tris-HCl buffer, pH 7.4; 100 mM ammonium acetate; 2 mM magnesium acetate; 1 mM ATP; 0.2 mM GTP; 
15 mM phosphocreatine; 3/rg of creatine kinase; 0.05 mM amino acids (minus leucine); 0.095 ,uCi L-[‘4C]leucine; 25 ~1 
rabbit reticulocyte lysate. When DTA was tested, 1 mM NAD was added to the reaction mixture. The incubations were 
conducted at 28°C for 5 min. The reaction was stopped with 1 ml of 0.1 M KOH, and the radioactivity incorporated 
into protein was measured as in [ 15 ]
Fig.1. Inhibition of cellular protein synthesis by PAP 
associated with reconstituted Sendai virus envelopes. 
Cells were incubated for 30 min at 37OC, washed and 
then supplements with MEM cont~ning 5% 
inactivated foetal calf serum. Protein synthesis was 
measured after 21 h with Friend’s cells and after 6 h 
with CHO cells as described in section 2. The amount of 
PAP associated with RSVE was estimated to be 50 pg of 
PAP in 1 mg of reconstituted viral envelope proteins. 
(O---O) Friend’s cells with PAP; (o---e) Friend’s cells 
with RSVE-associated PAP; (A---A) CHO cells with 
PAP; (A---A) CHO with RSVE-associate PAP. 
associated PAP from RSVE were unsuccessful. 
RSVE-[‘2s]PAP was incubated for 30 min at 
37”C, either in 0.2 M phosphate buffer (pH 1 l), in 
1 M NaCl, or in 2 M urea. The incubation mix- 
tures were Ioaded on a sucrose gradient (40010, 
20%, lo%, w/v), and were centrifuged at 100000 
x g for 1 h: a single peak of radioactivity was 
detected, which was associated with RSVE. 
Preliminary experiments indicated that RSVE 
containing any of the RIPS used, or DTA, in- 
hibited cellular protein synthesis, and that the 
respective IDso’s were related to the amount of in- 
hibitory protein associated with RSVE (not 
shown). Amongst the RIPS PAP was selected for 
further experiments, because it gave the highest ac- 
tivity associated with RSVE. Incubation with 
RSVE-PAP brought about a marked inhibition of 
protein synthesis by Friend’s erythroleukemic 
cells, the ZDSO being 0.5 ng/ml, comparable to that 
of ricin and abrin [ZO], whereas no inhibition of 
protein synthesis could be observed when the same 
cells were exposed to free PAP, at concentrations 
up to l-2 mg/ml (fig.1). Similar results were ob- 
tained with RSVE-PAP and CHO cells, although 
in this case the IDSO was 15 ng/ml. This diversity 
could be due to the different incubation times after 
the 30 min exposure to RSVE-PAP (6 h with 
CHO and 21 h with Friend’s cells). Addition to 
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Table 2 4. DISCUSSION 
Cytotoxicity of PAP-associated RSVE to Friend’s cells 
Protein synthesis 
(Yo of control) 
Assay system 
ng RSVE/ml 1000 200 50 
ng PAP/ml 50 10 2.5 
PAP alone 95 100 100 
RSVE alone 95 95 100 
PAP alone + empty RSVE 70 95 100 
PAP-associated RSVE - - 5 
PAP-associated RSVE 
pretreated with DTT” - 90 100 
PAP-associated RSVE 
pretreated with PMSFb - 85 90 
a Treatment was performed by incubating 50 pl of PAP- 
associated RSVE (viral protein 2.5 mg/ml) dissolved in 
medium A (pH 8.2) with 3 mM DTT at 37°C for 1 h. 
Then the mixture was diluted with Hank’s solution 
before the assay 
b Treatment was performed by addition of 3 ~1 of 
210 mM PMSF (methanol solution freshly prepared) 
to 200~1 of PAP-associated RSVE (viral protein 
0.125 mg/ml). The mixtures were incubated for 
30 min at 37°C and then diluted in Hank’s solution 
before the assay 
A new cytotoxic agent, as potent as ricin and 
similar natural toxins, was obtained by associating 
ribosome-inactivating proteins (PAP, gelonin, 
MCI) with reconstituted Sendai virus envelopes. 
The RIPS used did not affect protein synthesis by 
intact cells, as indicated in [3] and confirmed by 
our results with CHO and Friend’s cells. By con- 
trast, as little as 0.5 ng/ml of RSVE-RIP is suffi- 
cient to cause 50% inhibition of protein synthesis 
in Friend’s cells. Thus RIPS offer some advantages 
over DTA and probably the A-chains of other tox- 
ins in the preparation of cytotoxic agents with the 
use of RSVE. Our results suggest hat this high 
toxicity acquired by RIPS is due to the ability of 
viral envelopes to fuse with plasma membrane, 
with concomitant delivery of the RSVE-RIPS to 
cells. This is confirmed by the low toxicity of 
RSVE-RIPS treated with PMSF, which inhibits 
the fusion, but not the binding of RSVE [21]. 
Friend’s cells were washed 3-times in Hank’s solution, 
then the cells were exposed at 37’C for 30 min to the 
above system containing the indicated amount of PAP 
The experiments with RSVE-RIPS and 
RSVE-DTA disrupted with Triton X-100 suggest 
that as much as one half of inhibitory proteins re- 
mained exposed on the surface of the RSVE and 
apparently bound to viral envelope. Thus it is 
possible that the RSVE associated RIPS are 
transferred to the cells by a dual mechanism: 
(i) By delivery to the cytoplasm of the molecules 
entrapped inside the vesicles; 
and/or RSVE 
culture medium of mixtures of PAP and empty 
RSVE gave 30% inhibition of protein synthesis 
when 1 pg of RSVE was added to cells in the 
presence of 50 ng of PAP. 
(ii) By transfer to the host membrane of the 
molecules bound on the surface of the viral 
envelope [9]. 
To confirm that the internalization of RIPS was 
mediated by RSVE, viral glycoproteins were inac- 
tivated (table 2); in some experiments with a reduc- 
ing agent (DTT) which caused the loss of binding 
activity, and consequently of fusion ability of 
RSVE, and in other experiments with PMSF, a 
specific inhibitor of virus-cell fusion [21]. 
RSVE-PAP treated with both reagents no longer 
inhibited protein synthesis of Friend’s cells (table 
2). The same reagents did not affect the inhibitory 
activity of PAP on cell-free protein synthesis. 
RSVEs appear lOOO-times more effective than 
liposomes (phosphatidylserine liposomes) in carry- 
ing RIPS [7]. As shown in [lo], RSVEs are also ef- 
fective in carrying DTA which was not delivered by 
liposomes [7]. This difference is likely to be due to 
the fusion ability of RSVE. 
RSVEs bind to sialic acid residues on the cell 
surface, and consequently have a limited specifici- 
ty for different cells. However, the fact that it is 
possible to conjugate an antibody to Sendai virus, 
after removal of unspecific binding activity [22], 
makes this viral envelope a candidate to target a 
large amount of fully active macromolecules 
towards specific target cells. 
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